Newgenivf Group Limited's Business Segments

NewGenIvf Group Limited, a British Virgin Islands business company, is the surviving entity following a Business Combination involving ASCA and Legacy NewGenIvf. This combination included a reincorporation merger and an acquisition merger, resulting in Legacy NewGenIvf becoming a wholly-owned subsidiary of NewGenIvf Group Limited. Between February 2025 and March 2026, the company completed multiple reverse stock splits. As of December 31, 2025, NewGenIvf held approximately US$758,621 in cash and cash equivalents and had outstanding convertible promissory notes totaling $5,266,000 as of March 30, 2026. The company has access to an equity line of credit facility of up to US$100,000,000 from White Lion Capital, with approximately US$15.55 million drawn and converted to equity. NewGenIvf is monitoring market opportunities and conducting fundraising efforts to improve its cash flow position. The company faces risks related to its ability to continue as a going concern, with no assurance that required financing will be available on acceptable terms. Failure to secure sufficient capital could materially adversely affect the company and its financial statements.

NewGen IVF Group Limited specializes in providing advanced fertility treatments and reproductive health services. Their offerings are segmented into various categories that encompass a comprehensive approach to assisted reproductive technology (ART). Below is an extensive description of the segments, products, and services they offer:

1. Fertility Treatments
- In Vitro Fertilization (IVF): A primary service that involves the fertilization of an egg with sperm outside the body, followed by the transfer of the embryo to the uterus. NewGen offers personalized IVF programs tailored to individual patient needs.
- Intracytoplasmic Sperm Injection (ICSI): A specialized form of IVF where a single sperm is injected directly into an egg. This is particularly beneficial for male infertility cases.
- Preimplantation Genetic Testing (PGT): Testing embryos for genetic conditions before they are implanted to ensure the health of the future child. This includes PGT-A (aneuploidy) and PGT-M (monogenic disorders).
- Egg Freezing and Sperm Banking: Providing options for patients to preserve fertility by freezing eggs or sperm for future use, especially for individuals who may wish to delay parenthood or are undergoing medical treatments that affect fertility.
- Donor Services: Offering programs for using donor eggs or sperm, including screening and matching services to ensure quality and genetic compatibility.

Support Services
- Counseling and Psychological Support: Recognizing the emotional and psychological challenges faced by individuals undergoing fertility treatments, NewGen provides access to licensed counselors who specialize in reproductive health.
- Nutritional Consultancy: Offering guidance on nutrition and lifestyle choices that can improve fertility outcomes, including personalized diet plans and supplements that may support reproductive health.
- Legal Guidance: To navigate the complexities associated with donor agreements and contracts, NewGen provides legal support to ensure that all parties understand their rights and responsibilities.

Advanced Laboratory Techniques
- Embryology and Andrology Labs: State-of-the-art laboratories equipped with advanced technology for managing egg and sperm handling, fertilization processes, and embryo culture. NewGen employs highly qualified embryologists to oversee these processes.
- Cryopreservation Facilities: Utilizing advanced freezing techniques to preserve embryos, eggs, and sperm, ensuring that they remain viable for future use.

Education and Community Outreach
- Workshops and Seminars: Hosting educational events aimed at increasing awareness about fertility issues, treatment options, and advancements in reproductive technologies.
- Online Resources: Providing comprehensive resources and guides on fertility treatments, FAQs, and patient testimonials to empower individuals with knowledge about their reproductive health.

Research and Development
- Clinical Trials: Engaging in research initiatives aimed at developing new fertility treatments and improving existing techniques. This includes collaborations with research institutions and universities to remain at the forefront of reproductive medicine.
- Innovative Technologies: Investing in and utilizing cutting-edge technologies, such as artificial intelligence for embryo selection and telemedicine consultations that allow for remote patient interactions.

Partnerships and Collaborations
- Healthcare Affiliations: Collaborating with hospitals and medical professionals to provide comprehensive care and ensure that clients receive holistic treatment options that cover all aspects of reproductive health.

International Services
- Global Patients Program: Catering to international patients seeking fertility treatments, NewGen provides concierge services, including travel arrangements, local accommodation, and language support to ensure a seamless experience.

Conclusion
NewGen IVF Group Limited prides itself on its patient-centered approach, combining advanced technology with comprehensive care to support individuals and couples on their journey to parenthood. By offering a wide range of services that address not only the medical but also the emotional and supportive aspects of fertility treatment, NewGen aims to create a nurturing and empowering environment for all clients.